Atyr Pharma Inc. Revenue 2019–2025
Atyr Pharma Inc. annual/quarterly revenue history and growth rate from 2019 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Atyr Pharma Inc. revenue for the quarter ending September 30, 2025 was 190000.
- Atyr Pharma Inc. revenue for the twelve months ending September 30, 2025 was 190000, a 67.69% decrease year-over-year.
- Atyr Pharma Inc. annual revenue for 2025 was 190000, a 19.15% decrease from 2024.
- Atyr Pharma Inc. annual revenue for 2024 was 235000, a 33.43% decrease from 2023.
- Atyr Pharma Inc. annual revenue for 2023 was 353000, a 96.60% decrease from 2022.
- Atyr Pharma Inc. annual revenue for 2022 was 10.4 M.
Atyr Pharma Inc. (ATYR) — Frequently Asked Questions
Atyr Pharma Inc. (ATYR) is a publicly traded US company. It has a market capitalization of $43M. In fiscal 2025 it reported revenue of $190,000 and net income of -$74M. Explore ATYR's stock price, financial statements, earnings history, margins and key ratios below.
What is Atyr Pharma Inc.'s market cap?
Atyr Pharma Inc. (ATYR) has a market capitalization of $43M.
What is the ATYR stock price?
ATYR trades at $0.46 (-1.90% on the day).
How much revenue does Atyr Pharma Inc. make?
Atyr Pharma Inc. reported revenue of $190,000 in fiscal 2025.
Is ATYR profitable?
In fiscal 2025, Atyr Pharma Inc. reported net income of -$74M.